Ubs Asset Management Americas Inc Catalent, Inc. Transaction History
Ubs Asset Management Americas Inc
- $277 Billion
- Q1 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Catalent, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 559,135 shares of CTLT stock, worth $31.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
559,135
Previous 570,608
2.01%
Holding current value
$31.6 Million
Previous $25.6 Million
23.12%
% of portfolio
0.01%
Previous 0.01%
Shares
26 transactions
Others Institutions Holding CTLT
# of Institutions
484Shares Held
172MCall Options Held
865KPut Options Held
687K-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.15 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.2MShares$859 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA12.9MShares$730 Million0.12% of portfolio
-
Nomura Holdings Inc Tokyo, M011.3MShares$636 Million1.65% of portfolio
-
Janus Henderson Group PLC London, X09.56MShares$540 Million0.3% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $10.2B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...